Payne AB, Watts JA, Mitchell PK, Dascomb K, et al. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet 2024;404:1547-1559.
PMID: 39426837